Published in J Pharm Sci on September 01, 1985
The whiplash syndrome--common sense revisited. J Rheumatol (1997) 7.20
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
The use of standardized patients in the performance of a needs assessment and development of a CME intervention in rheumatology for primary care physicians. J Rheumatol (1997) 2.67
Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study. J Rheumatol (1999) 2.45
Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med (2001) 2.36
Serum transaminases during salicylate therapy. Br Med J (1971) 2.34
Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc (2003) 2.18
The genetics of psoriasis. Haplotype sharing in siblings with the disease. Arch Dermatol (1990) 2.12
Septic arthritis. Ann Rheum Dis (1972) 2.06
Development of persistent neurologic symptoms in patients with simple neck sprain. Arthritis Care Res (1999) 2.05
Alternative therapies--medicine, magic, or quackery. Who is winning the battle? J Rheumatol (1997) 2.00
Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol (2001) 1.93
Use of lumbar radiographs for the early diagnosis of low back pain. Proposed guidelines would increase utilization. JAMA (1997) 1.92
Cell-mediated immunity to herpes simplex virus in man. J Infect Dis (1974) 1.91
Telerobotic laparoscopic cholecystectomy: initial clinical experience with 25 patients. Ann Surg (2001) 1.83
Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making (2001) 1.75
Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol (1992) 1.69
An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J Rheumatol (1995) 1.62
Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol (1996) 1.60
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis. Ann Rheum Dis (1978) 1.45
Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun (1975) 1.43
Performance of online biomedical databases in rheumatology. J Rheumatol (1994) 1.42
[Expertise of current trends and future perspectives in rehabilitation research in Germany]. Rehabilitation (Stuttg) (2007) 1.41
The art versus the science of medicine. Are clinical practice guidelines the answer? Ann Rheum Dis (1998) 1.40
Combination drug therapy in rheumatoid arthritis. J Rheumatol (1997) 1.40
Comparative bioavailability of two flurbiprofen products: stereospecific versus conventional approach. Biopharm Drug Dispos (1991) 1.40
Generic health instruments do not comprehensively capture patient perceived improvement in patients with carpal tunnel syndrome. J Rheumatol (1999) 1.39
Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol (1997) 1.39
HLA-B27 and arthritis: back to the future. Part I. J Rheumatol (1991) 1.39
The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine. Clin Exp Rheumatol (1989) 1.38
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol (1999) 1.36
Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis (1977) 1.32
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. CMAJ (1996) 1.28
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003). Ann Rheum Dis (2003) 1.25
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther (2008) 1.23
Symptom expectation after minor head injury. A comparative study between Canada and Lithuania. Clin Neurol Neurosurg (2001) 1.21
Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol (1988) 1.20
Scintigraphic findings in ankylosing spondylitis. J Nucl Med (1977) 1.16
Scintigraphy of sacroiliac joints in acute anterior uveitis. A study of thirty patients. Ann Intern Med (1976) 1.16
Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies. Drug Metab Dispos (1987) 1.14
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
Investigation of sacroiliac disease: Comparative evaluation of radiological and radionuclide techniques. J Rheumatol (1975) 1.13
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
The scintigraphic investigation of sacroiliac disease. J Nucl Med (1977) 1.12
Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int (2006) 1.12
[The Bremen mortality index]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2004) 1.10
Cell-mediated immunity to herpes simplex virus in man. Am J Clin Pathol (1973) 1.10
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Cancer Care (Engl) (2010) 1.10
Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci (1988) 1.10
Management of rheumatoid arthritis: the historical context. J Rheumatol (2001) 1.09
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol (1989) 1.09
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
A re-examination of the whiplash associated disorders (WAD) as a systemic illness. Ann Rheum Dis (2005) 1.08
Neck injury and chronic pain syndromes: comment on the article by Buskila et al. Arthritis Rheum (1998) 1.08
Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol (1977) 1.07
The Hawthorne effect: can it be measured and utilized? Br J Anaesth (2013) 1.07
Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta. Biochem Biophys Res Commun (1987) 1.06
HL-A (transplantation) antigens in ankylosing spondylitis and Crohn's disease. J Rheumatol (1974) 1.06
Antimalarials in rheumatology: efficacy and safety. Semin Arthritis Rheum (1987) 1.06
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol (2001) 1.05
Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol (2001) 1.05
Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. Biochem Biophys Res Commun (1988) 1.04
Structured parent education in the management of childhood atopic dermatitis: the Berlin model. Patient Educ Couns (2000) 1.04
The best approach to the problem of whiplash? One ticket to Lithuania, please. Clin Exp Rheumatol (1999) 1.03
99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun (1995) 1.03
Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis (1975) 1.03
Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med (1988) 1.02
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol (1984) 1.02
Long-term effectiveness of antimalarial drugs in rheumatic diseases. Ann Rheum Dis (1998) 1.01
Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness. J Rheumatol (1995) 1.01
Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis (2003) 1.01
A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man. Immunology (1978) 1.01
Serum osmolality and outcome in intensive care unit patients. Acta Anaesthesiol Scand (2006) 1.00
Safety of laparoscopic approach for acute cholecystitis: retrospective study of 609 cases. World J Surg (2001) 1.00
Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol (1984) 1.00
Epidemiology of whiplash: an international dilemma. Ann Rheum Dis (1999) 0.99
Etodolac clinical pharmacokinetics. Clin Pharmacokinet (1994) 0.99
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology (1999) 0.98
Analysis of DNA structure by hydroxyapatite columns and ethidium bromide fluorescence techniques. A comparative study and effect on DNA binding. Arthritis Rheum (1978) 0.98
Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent. Can J Physiol Pharmacol (1999) 0.98
Electrocardiogram acquisition during MR examinations for patient monitoring and sequence triggering. Magn Reson Med (1994) 0.98
An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol (1998) 0.97
Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor. J Rheumatol (1996) 0.97
Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth (2001) 0.97
An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol (2000) 0.97
Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol (1999) 0.96
The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity. J Rheumatol (1982) 0.96
Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J Pharm Sci (1988) 0.96
Ibuprofen: a severe systemic reaction. Can Med Assoc J (1983) 0.96
Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol (1994) 0.96
Mucocutaneous lymph node syndrome in Canada. Can Med Assoc J (1975) 0.96